Indira R Singh, MD
Internal Medicine · San Pablo
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 12
- 1 carrier
- Office
- 1
Offices
1 location · University Healthcare Alliance · 334 clinicians in this group
Hospitals listed: 057190 · 059765 · 553127 · El Camino Health · Good Samaritan Hospital · Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
12 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Singh’s office at (510) 237-2802 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A149510 · Current
Licensed to practise in California · since 2017 · expires 2026-10-31 · University of Southern California Keck School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
- Good Samaritan HospitalSan Jose, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.337, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Good Samaritan Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 1 worse of 8 measures. Readmissions: 0 better, 5 the same, 4 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.337 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.75 (0 to 1.67) · 1,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.54 to 1.14) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 143.59 (98.7 to 188.49) · 98 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.7 · 45 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 100 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.7 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 573 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 820 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.5 · 482 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 3,711 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.12 (0 to 0.3) · 8,866 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.38) · 9,051 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.65 (0.74 to 4.56) · 1,929 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.8 (0.21 to 3.39) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.33 (0.88 to 3.78) · 1,836 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.73 (0 to 13.46) · 669 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.58 (3.96 to 11.19) · 654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.59 (0.13 to 3.04) · 496 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 0.87) · 7,373 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 152 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.08 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.542 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.484 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.565 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 327 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24.2 · 703 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 61.1 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 36.3 · 665 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 25.4 · 856 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19 · 978 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.3 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.3 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.2 · 135 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.8 (10.1 to 18.6) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 531 cases | No different | Jan 2024 – Dec 2024 |
What patients said (704 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 71% |
| Staff "always" explained | 54% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 38% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$118,232
Medicare paid this office $118,232 for 351 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 211 | $33,675 | $80 |
| Return visit (30+ min) | 129 | $22,370 | $117 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 67 | $19,659 | $289 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 67 | $10,256 | $153 |
| New patient visit (45+ min) | 65 | $9,438 | $145 |
See all 12 services
| Short return visit (20+ min) | 211 | $33,675 | $80 |
| Return visit (30+ min) | 129 | $22,370 | $117 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 67 | $19,659 | $289 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 67 | $10,256 | $153 |
| New patient visit (45+ min) | 65 | $9,438 | $145 |
| Short return visit | 82 | $4,343 | $38 |
| New patient visit (30+ min) | 50 | $3,858 | $77 |
| Influenza vaccine split virus, preservative free | 40 | $3,253 | $81 |
| Administration of pneumococcal vaccine | 67 | $2,599 | $38 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 89 | $1,838 | $15 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 22 | $1,665 | $49 |
| Administration of influenza virus vaccine | 43 | $1,643 | $38 |
Who their Medicare patients are
351 Original Medicare patients in 2024. Average age 75 · Under 65 3% · 85 and older 13% · Women 70% · Also on Medicaid 10% · Health risk score 1.10. At or below the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 65% · Coronary heart disease 24% · Diabetes 23% · Depression 19% · Cancer 17% · Chronic kidney disease 16% · Atrial fibrillation 14% · Heart failure 13% · COPD 8% · Stroke 8% · Dementia 7%.
The office billed $438,820, Medicare allowed $150,110 and paid $118,232; for 1,345 services of 31 kinds; $23,529 of it was for drugs given in the office and $94,702 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 351 | 1,345 | 75 | 1.10 | $438,820 | $118,232 |
| 2023 | 401 | 757 | 75 | 1.02 | $202,789 | $58,071 |
| 2022 | 502 | 959 | 77 | 1.03 | $216,844 | $63,659 |
| 2021 | 310 | 671 | 75 | 1.03 | $200,532 | $55,254 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 13 services
| Short return visit (20+ min) | 199 | $18,427 | $70 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 21 | $5,941 | $283 |
| Influenza vaccine split virus, preservative free | 81 | $5,826 | $72 |
| Long return visit (40+ min) | 51 | $5,202 | $100 |
| Return visit (30+ min) | 37 | $4,710 | $107 |
| Short return visit | 68 | $3,972 | $50 |
| Administration of influenza virus vaccine | 83 | $3,068 | $37 |
| New patient visit (45+ min) | 17 | $2,579 | $152 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 15 | $2,333 | $156 |
| New patient visit (30+ min) | 25 | $2,302 | $92 |
| New patient visit (15+ min) | 17 | $905 | $53 |
| Administration of pneumococcal vaccine | 21 | $776 | $37 |
| Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | 13 | $714 | $55 |
2022: 5 services
| Short return visit (20+ min) | 338 | $27,389 | $54 |
| Long return visit (40+ min) | 177 | $22,009 | $122 |
| Return visit (30+ min) | 75 | $6,726 | $80 |
| Short return visit | 122 | $4,251 | $30 |
| New patient visit (30+ min) | 11 | $803 | $73 |
2021: 10 services
| Return visit (30+ min) | 150 | $28,972 | $122 |
| Short return visit (20+ min) | 83 | $8,666 | $87 |
| New patient visit (30+ min) | 56 | $5,896 | $105 |
| Influenza vaccine split virus, preservative free | 38 | $2,480 | $65 |
| Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 30 mcg/0.3ml dosage, diluent reconstituted; third dose | 46 | $2,263 | $49 |
| Short return visit | 37 | $2,039 | $54 |
| Administration of influenza virus vaccine | 40 | $837 | $21 |
| Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 100 mcg/0.5ml dosage; third dose | 11 | $541 | $49 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 27 | $442 | $14 |
| Automated urinalysis test | 14 | $36 | $2 |
Medicaid work
$0 in 2021
Medicaid paid $0 for 68 billed services this clinician did in 2021, up to 20 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit | 46 | $0 |
| Long return visit (40+ min) | 22 | $0 |
| 2021 | 68 | 2 | 20 | $0 |
Drugs they prescribed that Part D paid
$260,985
Pharmacies billed $260,985 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 3% of their Part D prescriptions (100 of 3,019) in 2024. Above the middle of the specialty; the typical internal medicine clinician is at 1%. Long-acting opioids: 12% of their opioid prescriptions.
2,663 generic and fewer than 11 brand-name prescriptions · $260,985 in drug cost · 65 antibiotic prescriptions to 43 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ozempic | 31 | $41,678 | $1,344 |
| Jardiance | 36 | $37,248 | $1,035 |
| Eliquis | 30 | $30,653 | $1,022 |
| Vascepa | 39 | $16,504 | $423 |
| Januvia | 12 | $13,023 | $1,085 |
See all 64 drugs
| Ozempic | 31 | $41,678 | $1,344 |
| Jardiance | 36 | $37,248 | $1,035 |
| Eliquis | 30 | $30,653 | $1,022 |
| Vascepa | 39 | $16,504 | $423 |
| Januvia | 12 | $13,023 | $1,085 |
| Rosuvastatin | 155 | $2,338 | $15 |
| Levothyroxine | 151 | $1,855 | $12 |
| Bupropion Xl | 26 | $1,719 | $66 |
| Gabapentin | 69 | $1,494 | $22 |
| Atorvastatin | 141 | $1,258 | $9 |
| Albuterol Sulfate Hfa | 46 | $983 | $21 |
| Icosapent Ethyl | 13 | $955 | $73 |
| Hydrocodone-Acetaminophen | 39 | $897 | $23 |
| Losartan | 101 | $883 | $9 |
| Lisinopril | 82 | $780 | $10 |
| Ventolin Hfa | 13 | $746 | $57 |
| Fentanyl | 11 | $722 | $66 |
| Potassium Chloride | 31 | $711 | $23 |
| Estradiol | 19 | $703 | $37 |
| Tamsulosin | 63 | $697 | $11 |
| Amlodipine Besylate | 138 | $687 | $5 |
| Metoprolol | 49 | $592 | $12 |
| Ezetimibe | 34 | $518 | $15 |
| Zolpidem | 52 | $479 | $9 |
| Metformin Hcl Er | 41 | $419 | $10 |
| Escitalopram | 48 | $400 | $8 |
| Mirtazapine | 21 | $399 | $19 |
| Esomeprazole Magnesium | 14 | $371 | $27 |
| Simvastatin | 26 | $366 | $14 |
| Omeprazole | 58 | $347 | $6 |
| Fluticasone Propionate | 24 | $346 | $14 |
| Alendronate | 35 | $314 | $9 |
| Buspirone | 18 | $307 | $17 |
| Olmesartan Medoxomil | 15 | $271 | $18 |
| Diclofenac | 15 | $268 | $18 |
| Propranolol | 18 | $267 | $15 |
| Pantoprazole | 27 | $266 | $10 |
| Metformin | 39 | $253 | $6 |
| Montelukast | 14 | $252 | $18 |
| Allopurinol | 34 | $228 | $7 |
| Trazodone | 37 | $224 | $6 |
| Oxycodone | 14 | $205 | $15 |
| Hydrochlorothiazide | 52 | $194 | $4 |
| Valacyclovir | 19 | $191 | $10 |
| Hydralazine | 18 | $174 | $10 |
| Furosemide | 37 | $162 | $4 |
| Nitrofurantoin Mono-Macro | 18 | $135 | $8 |
| Famotidine | 16 | $133 | $8 |
| Tramadol | 31 | $132 | $4 |
| Lisinopril-Hydrochlorothiazide | 19 | $121 | $6 |
| Sertraline | 22 | $119 | $5 |
| Losartan-Hydrochlorothiazide | 15 | $112 | $7 |
| Pravastatin | 16 | $110 | $7 |
| Alprazolam | 30 | $109 | $4 |
| Fluoxetine | 32 | $103 | $3 |
| Carvedilol | 12 | $96 | $8 |
| Cyclobenzaprine | 11 | $90 | $8 |
| Triamterene-Hydrochlorothiazid | 12 | $75 | $6 |
| Atenolol | 15 | $67 | $4 |
| Azithromycin | 12 | $61 | $5 |
| Meloxicam | 12 | $58 | $5 |
| Spironolactone | 11 | $54 | $5 |
| Metoprolol | 12 | $33 | $3 |
| Lorazepam | 13 | $21 | $2 |
Year by year
| 2024 | 3,019 | 450 | 3% (100) | None | $260,985 |
| 2023 | 2,975 | 709 | 1% (36) | 11% | $260,788 |
| 2022 | 4,136 | 738 | 2% (76) | 13% | $698,379 |
| 2021 | 1,550 | 321 | 3% (53) | None | $155,489 |
| 2020 | 102 | 48 | 0% (0) | None | $8,374 |
| 2019 | 798 | 287 | None | None | $69,042 |
| 2018 | 323 | 143 | None | None | $25,275 |
| 2017 | 60 | 19 | 0% (0) | None | $12,815 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 61 drugs
| Eliquis | 28 | $37,909 | $1,354 |
| Xarelto | 19 | $30,244 | $1,592 |
| Jardiance | 24 | $28,648 | $1,194 |
| Ozempic | 11 | $14,262 | $1,297 |
| Trulicity | 13 | $12,874 | $990 |
| Atorvastatin | 291 | $3,796 | $13 |
| Levothyroxine | 157 | $2,965 | $19 |
| Synthroid | 22 | $1,793 | $81 |
| Rosuvastatin | 121 | $1,708 | $14 |
| Gabapentin | 68 | $1,454 | $21 |
| Albuterol Sulfate Hfa | 44 | $1,429 | $32 |
| Losartan | 87 | $1,421 | $16 |
| Valsartan | 20 | $1,392 | $70 |
| Amlodipine Besylate | 132 | $1,249 | $9 |
| Fluticasone Propionate | 46 | $1,115 | $24 |
| Tamsulosin | 65 | $992 | $15 |
| Metoprolol | 54 | $951 | $18 |
| Metformin Hcl Er | 62 | $924 | $15 |
| Pravastatin | 41 | $821 | $20 |
| Lisinopril | 107 | $779 | $7 |
| Irbesartan | 14 | $761 | $54 |
| Potassium Chloride | 32 | $699 | $22 |
| Bupropion Xl | 24 | $680 | $28 |
| Diclofenac | 20 | $678 | $34 |
| Allopurinol | 39 | $671 | $17 |
| Escitalopram | 29 | $650 | $22 |
| Omeprazole | 41 | $577 | $14 |
| Clopidogrel | 22 | $558 | $25 |
| Pantoprazole | 29 | $550 | $19 |
| Sertraline | 35 | $513 | $15 |
| Chlorthalidone | 35 | $466 | $13 |
| Trazodone | 31 | $464 | $15 |
| Metformin | 34 | $452 | $13 |
| Hydrocodone-Acetaminophen | 16 | $452 | $28 |
| Hydrochlorothiazide | 81 | $405 | $5 |
| Ezetimibe | 14 | $401 | $29 |
| Baclofen | 13 | $368 | $28 |
| Simvastatin | 33 | $354 | $11 |
| Montelukast | 25 | $351 | $14 |
| Celecoxib | 20 | $304 | $15 |
| Zolpidem | 33 | $302 | $9 |
| Famotidine | 20 | $281 | $14 |
| Furosemide | 39 | $266 | $7 |
| Carvedilol | 12 | $259 | $22 |
| Finasteride | 15 | $250 | $17 |
| Metoprolol | 28 | $243 | $9 |
| Olmesartan Medoxomil | 11 | $239 | $22 |
| Hydralazine | 15 | $218 | $15 |
| Mirtazapine | 11 | $207 | $19 |
| Sumatriptan | 11 | $200 | $18 |
| Nitrofurantoin Mono-Macro | 18 | $186 | $10 |
| Fluoxetine | 12 | $169 | $14 |
| Lovastatin | 14 | $159 | $11 |
| Triamcinolone Acetonide | 13 | $158 | $12 |
| Hydroxyzine | 13 | $157 | $12 |
| Alendronate | 13 | $135 | $10 |
| Paxlovid (Eua) | 12 | $123 | $10 |
| Atenolol | 15 | $114 | $8 |
| Prednisone | 13 | $95 | $7 |
| Alprazolam | 17 | $85 | $5 |
| Azithromycin | 16 | $78 | $5 |
2022: 80 drugs
| Xarelto | 61 | $70,072 | $1,149 |
| Eliquis | 60 | $53,388 | $890 |
| Trulicity | 22 | $24,634 | $1,120 |
| Januvia | 25 | $23,401 | $936 |
| Jardiance | 25 | $17,849 | $714 |
| Wixela Inhub | 27 | $10,254 | $380 |
| Flovent Hfa | 21 | $7,345 | $350 |
| Symbicort | 11 | $7,087 | $644 |
| Atorvastatin | 361 | $5,074 | $14 |
| Vascepa | 11 | $4,883 | $444 |
| Rosuvastatin | 114 | $4,668 | $41 |
| Levothyroxine | 145 | $3,214 | $22 |
| Synthroid | 35 | $2,728 | $78 |
| Valsartan | 35 | $2,650 | $76 |
| Gabapentin | 63 | $2,568 | $41 |
| Albuterol Sulfate Hfa | 47 | $2,247 | $48 |
| Losartan | 84 | $1,619 | $19 |
| Escitalopram | 81 | $1,573 | $19 |
| Metoprolol | 75 | $1,507 | $20 |
| Tamsulosin | 80 | $1,504 | $19 |
| Amlodipine Besylate | 158 | $1,461 | $9 |
| Pravastatin | 77 | $1,415 | $18 |
| Diltiazem 24hr Er (Cd) | 13 | $1,337 | $103 |
| Bupropion Xl | 40 | $1,330 | $33 |
| Valacyclovir | 19 | $1,306 | $69 |
| Duloxetine | 20 | $1,304 | $65 |
| Ezetimibe | 33 | $1,205 | $37 |
| Omeprazole | 61 | $1,106 | $18 |
| Pantoprazole | 45 | $1,056 | $23 |
| Lisinopril | 148 | $998 | $7 |
| Trazodone | 77 | $990 | $13 |
| Divalproex | 19 | $945 | $50 |
| Potassium Chloride | 32 | $938 | $29 |
| Fluticasone Propionate | 36 | $875 | $24 |
| Diclofenac | 30 | $821 | $27 |
| Metformin Hcl Er | 63 | $777 | $12 |
| Chlorthalidone | 23 | $765 | $33 |
| Simvastatin | 70 | $756 | $11 |
| Levetiracetam | 16 | $719 | $45 |
| Hydrochlorothiazide | 110 | $701 | $6 |
| Hydrocodone-Acetaminophen | 32 | $698 | $22 |
| Donepezil | 35 | $684 | $20 |
| Allopurinol | 50 | $623 | $12 |
| Baclofen | 12 | $559 | $47 |
| Metformin | 57 | $548 | $10 |
| Irbesartan | 12 | $520 | $43 |
| Montelukast | 29 | $518 | $18 |
| Estradiol | 16 | $517 | $32 |
| Carvedilol | 24 | $491 | $20 |
| Mirtazapine | 20 | $475 | $24 |
| Metoprolol | 43 | $451 | $10 |
| Zolpidem | 48 | $435 | $9 |
| Klor-Con 10 | 12 | $410 | $34 |
| Finasteride | 26 | $404 | $16 |
| Atenolol | 31 | $380 | $12 |
| Sumatriptan | 13 | $374 | $29 |
| Fluoxetine | 32 | $363 | $11 |
| Furosemide | 58 | $332 | $6 |
| Sertraline | 28 | $330 | $12 |
| Benazepril | 16 | $277 | $17 |
| Glipizide Er | 11 | $261 | $24 |
| Triamterene-Hydrochlorothiazid | 16 | $248 | $16 |
| Buspirone | 14 | $232 | $17 |
| Famotidine | 19 | $218 | $11 |
| Cyclobenzaprine | 18 | $211 | $12 |
| Clopidogrel | 20 | $209 | $10 |
| Triamcinolone Acetonide | 23 | $204 | $9 |
| Hydralazine | 17 | $199 | $12 |
| Lovastatin | 15 | $186 | $12 |
| Pioglitazone | 15 | $181 | $12 |
| Alendronate | 15 | $173 | $12 |
| Hydroxyzine | 15 | $164 | $11 |
| Tramadol | 27 | $157 | $6 |
| Citalopram Hbr | 14 | $155 | $11 |
| Diazepam | 25 | $138 | $6 |
| Paxlovid (Eua) | 12 | $113 | $9 |
| Lorazepam | 20 | $95 | $5 |
| Ibuprofen | 13 | $85 | $7 |
| Alprazolam | 20 | $65 | $3 |
| Prednisone | 16 | $39 | $2 |
2021: 42 drugs
| Januvia | 24 | $16,598 | $692 |
| Xarelto | 18 | $12,659 | $703 |
| Jardiance | 18 | $9,563 | $531 |
| Eliquis | 14 | $9,190 | $656 |
| Lantus Solostar | 12 | $7,244 | $604 |
| Aripiprazole | 14 | $3,106 | $222 |
| Atorvastatin | 91 | $3,062 | $34 |
| Levetiracetam | 23 | $1,490 | $65 |
| Divalproex | 22 | $1,219 | $55 |
| Albuterol Sulfate Hfa | 25 | $1,215 | $49 |
| Amlodipine Besylate | 72 | $1,050 | $15 |
| Duloxetine | 19 | $850 | $45 |
| Carvedilol | 27 | $847 | $31 |
| Tamsulosin | 30 | $716 | $24 |
| Levothyroxine | 45 | $696 | $15 |
| Montelukast | 15 | $678 | $45 |
| Omeprazole | 17 | $618 | $36 |
| Simvastatin | 28 | $617 | $22 |
| Hydrocodone-Acetaminophen | 31 | $504 | $16 |
| Escitalopram | 16 | $490 | $31 |
| Losartan | 28 | $484 | $17 |
| Gabapentin | 25 | $427 | $17 |
| Potassium Chloride | 22 | $405 | $18 |
| Trazodone | 27 | $377 | $14 |
| Lisinopril | 38 | $372 | $10 |
| Hydralazine | 19 | $356 | $19 |
| Clotrimazole | 17 | $339 | $20 |
| Isosorbide Mononitrate Er | 14 | $331 | $24 |
| Rosuvastatin | 11 | $305 | $28 |
| Furosemide | 41 | $293 | $7 |
| Diclofenac | 13 | $274 | $21 |
| Benazepril | 20 | $268 | $13 |
| Metoprolol | 18 | $266 | $15 |
| Metformin | 26 | $264 | $10 |
| Triamcinolone Acetonide | 23 | $187 | $8 |
| Metformin Hcl Er | 14 | $185 | $13 |
| Nitrofurantoin Mono-Macro | 14 | $165 | $12 |
| Metoprolol | 17 | $159 | $9 |
| Hydrochlorothiazide | 18 | $130 | $7 |
| Lorazepam | 13 | $114 | $9 |
| Prednisone | 12 | $71 | $6 |
| Tramadol | 11 | $51 | $5 |
2020: 1 drug
| Betamethasone Dipropionate | 18 | $1,589 | $88 |
2019: 20 drugs
| Atorvastatin | 44 | $1,120 | $25 |
| Proair Hfa | 14 | $1,037 | $74 |
| Losartan | 37 | $822 | $22 |
| Levothyroxine | 21 | $701 | $33 |
| Diclofenac | 12 | $594 | $49 |
| Amlodipine Besylate | 70 | $579 | $8 |
| Omeprazole | 23 | $430 | $19 |
| Pravastatin | 11 | $373 | $34 |
| Hydralazine | 14 | $329 | $23 |
| Gabapentin | 16 | $310 | $19 |
| Hydrochlorothiazide | 18 | $220 | $12 |
| Lisinopril | 20 | $219 | $11 |
| Furosemide | 18 | $169 | $9 |
| Azithromycin | 27 | $155 | $6 |
| Alendronate | 11 | $140 | $13 |
| Pantoprazole | 12 | $133 | $11 |
| Atenolol | 12 | $127 | $11 |
| Fluticasone Propionate | 13 | $84 | $6 |
| Metformin | 11 | $83 | $8 |
| Prednisone | 12 | $30 | $2 |
2018: 6 drugs
| Atorvastatin | 24 | $446 | $19 |
| Omeprazole | 23 | $271 | $12 |
| Amlodipine Besylate | 22 | $152 | $7 |
| Losartan | 12 | $141 | $12 |
| Metformin | 11 | $107 | $10 |
| Lisinopril | 11 | $107 | $10 |
Money from drug and device companies
$47 in 2022
| 2022 | 1 | 1 | None | $47 |
| 2020 | 1 | 4 | None | $1,421 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Baxter Healthcare | None | $47 | 1 payment
|
See the published payment
| Baxter Healthcare | Debt forgiveness · 2022-01-06 | None | $47 |
See earlier years (2020)
2020: $1,421
| Pfizer | None | $1,421 | 4 payments
|
Professional record
- NPI
- 1194102632
- Licence
- CA A149510California A149510: Current · expires 2026-10-31
- Trained
- University of Southern California Keck School of Medicine, 2015
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Medicaid ID
- CA IS3232267556
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 14251 Winchester Blvd Ste 200, Los Gatos, CA, 95032
- NPI first listed
- 2015-05-05
- NPI last updated
- 2024-04-23
- NPI record certified
- 2024-04-23
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 5800 Hollis St, Emeryville, CA, 94608